FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stefano Cascinu

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Luca Faloppi; Kalliopi Andrikou; Stefano Cascinu
Cetuximab: still an option in the treatment of pancreatic cancer?
MARIO SCARTOZZI; M Bianconi; A Bittoni; L Burattini; M Del Prete; L Faloppi; R Giampieri; Cristian Loretelli; E Maccaroni; D Minardi; R Montironi; G Muzzonigro; S Nicoletti; Stefano Cascinu
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib.
Matteo Santoni; Mimma Rizzo; Rossana Berardi; Luciano Burattini; Giacomo Carteni; Stefano Cascinu
Novel Agents, Combinations and Sequences for the Treatment of Advanced Renal Cell Carcinoma: When is the Revolution Coming?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stefano Cascinu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Luca Faloppi; Kalliopi Andrikou; Stefano Cascinu
Cetuximab: still an option in the treatment of pancreatic cancer?
Expert opinion on biological therapy 2013;13(5):791-801.
2013: MARIO SCARTOZZI; M Bianconi; A Bittoni; L Burattini; M Del Prete; L Faloppi; R Giampieri; Cristian Loretelli; E Maccaroni; D Minardi; R Montironi; G Muzzonigro; S Nicoletti; Stefano Cascinu
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib.
British journal of cancer 2013;108(5):1126-32.
2013: Matteo Santoni; Mimma Rizzo; Rossana Berardi; Luciano Burattini; Giacomo Carteni; Stefano Cascinu
Novel Agents, Combinations and Sequences for the Treatment of Advanced Renal Cell Carcinoma: When is the Revolution Coming?
Current cancer drug targets 2013;13(3):313-25.
2013: Alessandro Bittoni; Maristella Bianconi; Michela Del Prete; Luca Faloppi; Riccardo Giampieri; Elena Maccaroni; MARIO SCARTOZZI; Stefano Cascinu
The Tower of Babel of liver metastases from colorectal cancer: are we ready for one language?
Critical reviews in oncology/hematology 2013;85(3):332-41.
2013: Elisa Fontana; Salvatore Galdy; Francesco Leonardi; Pier Luigi Losardo; Francesca Virginia Negri; Francesca Pucci; Luigi Roncoroni; Simona Bui; Roberta Camisa; Stefano Cascinu; Pellegrino Crafa; Paolo Dell'Abate; Elisa Anselmi; Andrea Ardizzoni
Long-term results of preoperative 5-fluorouracil-oxaliplatin chemoradiation therapy in locally advanced rectal cancer.
Anticancer research 2013;33(2):725-30.
2013: Luisa Fioretto; Carmelo Iacono; Roberto Labianca; Stefano Cascinu; Vittorina Zagonel
The MaiSON Project (Italy). Developing integration strategies for oncology organizations/associations through a participatory approach.
Tumori 2013;99(1):122-4.
2013: Rossana Berardi; Miriam Caramanti; Zelmira Ballatore; Mariagrazia De Lisa; Paola Mazzanti; Francesca Morgese; Azzurra Onofri; Silvia Pagliaretta; Chiara Pierantoni; Mirco Pistelli; Silvia Rinaldi; Matteo Santoni; Agnese Savini; Stefano Cascinu
Role of maspin in cancer.
Clinical and translational medicine 2013;2(1):8.
2013: Rossana Berardi; Alen Federici; Federico Mocchegiani; Francesca Morgese; Daniele Nicolini; Azzurra Onofri; Chiara Pierantoni; Andrea Risaliti; Marco Vivarelli; Stefano Cascinu
Resected biliary tract cancers: a novel clinical-pathological score correlates with global outcome.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2013;45(1):70-4.
2012: Laura Belvederesi; Francesca Bianchi; Raffaella Bracci; Stefano Cascinu; Cristian Loretelli; Riccardo Cellerino
Sub-cellular localization analysis of MSH6 missense mutations does not reveal an overt MSH6 nuclear transport impairment.
Familial cancer 2012;11(4):675-80.
2012: Manfred P Lutz; Christophe Mariette; Markus Moehler; Florian Otto; Tsuneo Oyama; Arnaud Roth; Josef Rueschoff; Thomas Ruhstaller; Raquel Seruca; Michael Stahl; Florian Sterzing; Eric van Cutsem; Ate van der Gaast; Jan van Lanschot; Marc Ychou; John R Zalcberg; Jaffer A Ajani; William Allum; Daniela Aust; Yung-Jue Bang; Stefano Cascinu; Michel Ducreux; Arnulf Hölscher; Janusz Jankowski; Edwin P M Jansen; Ralf Kisslich; Florian Lordick
Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
European journal of cancer (Oxford, England : 1990) 2012;48(16):2941-53.
2012: Daniele Santini; M Scartozzi; Gaia Schiavon; O Venditti; Bruno Vincenzi; Raffaele Addeo; G Bronte; Stefano Cascinu; Giuseppe Cicero; Alfredo Falcone; A M Frezza; C Garufi; M Imperatori; E Maiello; A Mancuso; G Masi; F Recine; A Russo; Giuseppe Tonini
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(9):2313-8.
2012: Matteo Santoni; Valerio Farfariello; Mimma Rizzo; Giorgio Santoni; Rossana Berardi; Luciano Burattini; Giacomo Carteni; Stefano Cascinu
Present and future of tyrosine kinase inhibitors in renal cell carcinoma: analysis of hematologic toxicity.
Recent patents on anti-infective drug discovery 2012;7(2):104-10.
2012: Rossana Berardi; Tommasina Biscotti; Italo Bearzi; Mario Guerrieri; Elena Maccaroni; Alessandra Mandolesi; Giovanna Mantello; Cristina Marmorale; Azzurra Onofri; Chiara Pierantoni; Walter Siquini; Stefano Cascinu
Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2012;44(7):617-22.
2012: MARIO SCARTOZZI; R Silva; alberto zaniboni; Italo Bearzi; S Biagetti; T Biscotti; Alfredo Falcone; Eva Galizia; R Giampieri; Lucio Giustini; Fotios Loupakis; E Maccaroni; Alessandra Mandolesi; Stefano Cascinu
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(7):1706-12.
2012: Alberto Zaniboni; Giuseppe Valmadre; Enzo Veltri; Enrico Aitini; Sandro Barni; Stefano Cascinu; Vincenzo Catalano; Claudio Codignola; Domenica Ferrara; Daris Ferrari; Roberto Labianca
FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study.
Cancer chemotherapy and pharmacology 2012;69(6):1641-5.
2012: Alessandro Brunelli; Stefano Cascinu; Paola Mazzanti; Azzurra Onofri; Cecilia Pompili; Rossana Berardi; Michele Salati; Armando Sabbatini
Performance at preoperative stair-climbing test is associated with prognosis after pulmonary resection in stage I non-small cell lung cancer.
The Annals of thoracic surgery 2012;93(6):1796-800.
2012: Andrea Bonacchi; Stefano Cascinu; Paolo Catanzaro; Francesco Di Costanzo; Laura Doni; Monica Guazzini; Mariangela Martire; Guido Miccinesi; Roberta Perfetto; Vincenzo Adamo; Silvia Bacci; Laura Bellotti; Alessandra Rossi; Alessandro Toccafondi; Massimo Rosselli
Temperament and character traits associated with health-related quality of life in cancer patients.
Tumori 2012;98(3):377-84.
2012: Rossana Berardi; Alessandro Brunelli; Italo Bearzi; Stefano Gasparini; Paola Mazzanti; Azzurra Onofri; Alessandra Pagliacci; Chiara Pierantoni; Eleonora Pisa; Armando Sabbatini; Alfredo Santinelli; Daniela Stramazzotti; L Zuccatosta; Stefano Cascinu
Maspin expression is a favorable prognostic factor in non-small cell lung cancer.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2012;34(2):72-8.
2012: Anna Campanati; Stefano Cascinu; I Conte; K Giuliodori; F Marcucci; E Molinelli; A Onofri; Chiara Pierantoni; Rossana Berardi; Annamaria Offidani
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(4):1081-2.
2012: Giampietro Gasparini; Yukiko Mori; Paola Morosini; Satoshi Nagayama; Junichi Shishido; Francesco Torino; Teresa Troiani; Takayuki Ueno; Akihiko Yoshizawa; Alberto Ballestrero; Rossana Berardi; Stefano Cascinu; Masakazu Toi
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer.
Angiogenesis 2012;15(1):141-50.
2012: MARIO SCARTOZZI; Laura Belvederesi; M Bianconi; A Bittoni; M Del Prete; L Faloppi; Eva Galizia; R Giampieri; Cristian Loretelli; E Maccaroni; Stefano Cascinu
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients.
British journal of cancer 2012;106(5):799-804.
2012: Maristella Bianconi; Alessandro Bittoni; Luciano Burattini; Michela Del Prete; Luca Faloppi; Riccardo Giampieri; Elena Maccaroni; MARIO SCARTOZZI; Stefano Cascinu
Angiogenetic pathway as a therapeutic target in renal cell carcinoma.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2012;34(1):15-22.
2012: Alessandro Bittoni; Luca Faloppi; Riccardo Giampieri; Stefano Cascinu
Selecting the best treatment for an individual patient.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2012;196():307-18.
2012: Matteo Santoni; Luciano Burattini; Stefano Cascinu; Francesco Catanzariti; Daniele Minardi; Giovanni Muzzonigro; Massimo Nabissi; Giorgio Santoni
Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Proteins in Urothelial Cell Carcinoma of Human Bladder.
Advances in urology 2012;2012():397412.
2012: MARIO SCARTOZZI; Michela Del Prete; Italo Bearzi; Laura Belvederesi; Francesca Bianchi; Maristella Bianconi; Alessandro Bittoni; Luca Faloppi; Eva Galizia; Riccardo Giampieri; Cristian Loretelli; Alessandra Mandolesi; Mirco Pistelli; Stefano Cascinu
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients.
PloS one 2012;7(7):e38192.
2012: MARIO SCARTOZZI; Simona Alfonsi; Italo Bearzi; Simona Biagetti; Maristella Bianconi; Alessandro Bittoni; Michela Del Prete; Luca Faloppi; Riccardo Giampieri; Lucio Giustini; Cristian Loretelli; Elena Maccaroni; Alessandra Mandolesi; Stefano Cascinu
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab.
Journal of translational medicine 2012;10():71.
2012: MARIO SCARTOZZI; Gianluca Svegliati-Baroni; Laura Belvederesi; Maristella Bianconi; Alessandro Bittoni; Michela Del Prete; Luca Faloppi; Riccardo Giampieri; Cristian Loretelli; Elena Maccaroni; Stefano Cascinu
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management.
PloS one 2012;7(3):e32653.
2011: Rossana Berardi; S Miseria; Stefano Cascinu
Professional failure: how do oncologists feel it?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(12):2696-7.
2011: Rossana Berardi; Alessandro Brunelli; Stefano Gasparini; Paola Mazzanti; Azzurra Onofri; Chiara Pierantoni; Eleonora Pisa; Armando Sabbatini; Alfredo Santinelli; MARIO SCARTOZZI; Daniela Stramazzotti; L Zuccatosta; Stefano Cascinu
Epidermal growth factor receptor status in stages of resected non-small cell lung cancer: implications for treatment with epidermal growth factor receptor inhibitors.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2011;33(4):196-204.
2011: Nicola Battelli; Alessandro Bittoni; Carlo Mariotti; Alessandra Pagliacci; MARIO SCARTOZZI; Laura Zepponi; Stefano Cascinu
Doses of capecitabine and oral vinorelbine are not relevant for efficacy in breast cancer patients: an analysis of dose intensity.
Tumori 2011;97(4):449-53.
2011: Stefano Cascinu; Francesco Ferraù; Eva Galizia; Roberto Labianca; Gabriele Luppi; Francesca Pucci; Rossana Berardi; Giordano Domenico Beretta; Rosa Rita Silva; MARIO SCARTOZZI
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.
Cancer chemotherapy and pharmacology 2011;68(1):37-43.
2011: MARIO SCARTOZZI; Italo Bearzi; Alessandra Mandolesi; R Giampieri; L Faloppi; Eva Galizia; Fotios Loupakis; alberto zaniboni; Fausto Zorzi; T Biscotti; Roberto Labianca; Alfredo Falcone; Stefano Cascinu
Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients.
British journal of cancer 2011;104(11):1786-90.
2011: Eric Van Cutsem; Claus-Henning Köhne; István Láng; Gunnar Folprecht; Marek P Nowacki; Stefano Cascinu; Igor Shchepotin; Joan Maurel; D Cunningham; Sabine Tejpar; Michael Schlichting; Angela Zubel; Ilhan Celik; Philippe Rougier; Fortunato Ciardiello
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(15):2011-9.
2011: Mirco Pistelli; MARIO SCARTOZZI; Rossana Berardi; Alessandro Bittoni; Eva Galizia; Stefano Cascinu
Second-line chemotherapy with irinotecan, 5-fluorouracil and leucovorin (FOLFIRI) in relapsed or metastatic gastric cancer: lessons from clinical practice.
Tumori 2011;97(3):275-9.
2011: Luca Faloppi; MARIO SCARTOZZI; Elena Maccaroni; Marzia Di Pietro Paolo; Rossana Berardi; Michela Del Prete; Stefano Cascinu
Evolving strategies for the treatment of hepatocellular carcinoma: from clinical-guided to molecularly-tailored therapeutic options.
Cancer treatment reviews 2011;37(3):169-77.
2011: MARIO SCARTOZZI; C Loretelli; Italo Bearzi; Alessandra Mandolesi; Eva Galizia; A Onofri; M Pistelli; A Bittoni; Rossana Berardi; Stefano Cascinu
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(4):897-902.
2011: MARIO SCARTOZZI; Walter Siquini; Eva Galizia; Pierpaolo Stortoni; Cristina Marmorale; Rossana Berardi; Aroldo Fianchini; Stefano Cascinu
The timing of surgery for resectable metachronous liver metastases from colorectal cancer: Better sooner than later? A retrospective analysis.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2011;43(3):194-8.
2011: MARIO SCARTOZZI; Maristella Bianconi; Elena Maccaroni; Riccardo Giampieri; Michela Del Prete; Rossana Berardi; Stefano Cascinu
State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors.
Discovery medicine 2011;11(57):144-53.
2011: MARIO SCARTOZZI; Elena Maccaroni; Riccardo Giampieri; Mirco Pistelli; Alessandro Bittoni; Michela Del Prete; Rossana Berardi; Stefano Cascinu
5-Fluorouracil pharmacogenomics: still rocking after all these years?
Pharmacogenomics 2011;12(2):251-65.
2011: MARIO SCARTOZZI; Alessandra Mandolesi; Riccardo Giampieri; Alessandro Bittoni; Chiara Pierantoni; alberto zaniboni; Eva Galizia; Lucio Giustini; Rosa Rita Silva; Renato Bisonni; Rossana Berardi; Tommasina Biscotti; Simona Biagetti; Italo Bearzi; Stefano Cascinu
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab.
The oncologist 2011;16(1):53-60.
2010: MARIO SCARTOZZI; Alessandra Mandolesi; Riccardo Giampieri; Chiara Pierantoni; Fotios Loupakis; alberto zaniboni; Eva Galizia; Lucio Giustini; Rosa Rita Silva; Renato Bisonni; Rossana Berardi; Simona Biagetti; Stefano Menzo; Alfredo Falcone; Italo Bearzi; Stefano Cascinu
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan.
International journal of cancer. Journal international du cancer 2010;127(8):1941-7.
2010: Fotios Loupakis; Gianluca Masi; Lorenzo Fornaro; Enrico Vasile; Giacomo Allegrini; Eloise Fontana; Cristina Granetto; Lisa Salvatore; Lucia Mentuccia; Michele Andreuccetti; Enrico Cortesi; Marco Merlano; Stefano Cascinu; Alfredo Falcone
Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma.
Cancer chemotherapy and pharmacology 2010;66(3):559-66.
2010: MARIO SCARTOZZI; Maristella Bianconi; Elena Maccaroni; Riccardo Giampieri; Rossana Berardi; Stefano Cascinu
Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer.
Current opinion in molecular therapeutics 2010;12(3):361-71.
2010: Giordano Domenico Beretta; MARIO SCARTOZZI; Luca Tondulli; Stefano Cascinu
Chemotherapy-free intervals in patients with metastatic colorectal cancer: a tale of two cities?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(16):e268-9; author reply e270.
2010: MARIO SCARTOZZI; Paola Mazzanti; Riccardo Giampieri; Rossana Berardi; Eva Galizia; S Gasparini; L Zuccatosta; Stefano Cascinu
Clinical predictive factors for advanced non-small cell lung cancer (NSCLC) patients receiving third-line therapy: Selecting the unselectable?
Lung cancer (Amsterdam, Netherlands) 2010;68(3):433-7.
2010: Stefano Cascinu; M Falconi; V Valentini; S Jelic
Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21 Suppl 5():v55-8.
2010: MARIO SCARTOZZI; Mirco Pistelli; Alessandro Bittoni; Riccardo Giampieri; Eva Galizia; Rossana Berardi; Luca Faloppi; Michela Del Prete; Stefano Cascinu
Novel perspectives for the treatment of gastric cancer: from a global approach to a personalized strategy.
Current oncology reports 2010;12(3):175-85.
2010: A Bittoni; E Maccaroni; MARIO SCARTOZZI; Rossana Berardi; Stefano Cascinu
Chemotherapy for locally advanced and metastatic gastric cancer: state of the art and future perspectives.
European review for medical and pharmacological sciences 2010;14(4):309-14.
2010: Salvatore Siena; L Crinò; M Danova; S Del Prete; Stefano Cascinu; S Salvagni; I Schiavetto; M Vitali; Emilio Bajetta
Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(3):655-61.
2010: MARIO SCARTOZZI; Gianluca Svegliati Baroni; Luca Faloppi; Marzia Di Pietro Paolo; Chiara Pierantoni; R Candelari; Rossana Berardi; Stefania Antognoli; Cinzia Mincarelli; Andrea Risaliti; Cristina Marmorale; Ettore Antico; Antonio Benedetti; Stefano Cascinu
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis.
Journal of experimental & clinical cancer research : CR 2010;29():164.
2010: Rossana Berardi; Azzurra Onofri; Mirco Pistelli; Elena Maccaroni; MARIO SCARTOZZI; Chiara Pierantoni; Stefano Cascinu
Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer.
Core evidence 2010;5():61-76.
2010: Giorgio Cocconi; Caterina Caminiti; Giovanni Zaninetta; Rodolfo Passalacqua; Stefano Cascinu; Francesco Campione; Renata Todeschini; Sergio Zani; Tiberio d'Aloia; Luigi Migone
National survey of medical choices in caring for terminally ill patients in Italy, a cross-sectional study.
Tumori 2010;96(1):122-30.
2009: MARIO SCARTOZZI; Italo Bearzi; Alessandra Mandolesi; Eva Galizia; Chiara Pierantoni; Fotios Loupakis; Rossana Berardi; alberto zaniboni; Antonello Quadri; Fausto Zorzi; Simona Biagetti; Cristian Loretelli; Tommasina Biscotti; Roberto Labianca; Gianluca Masi; Alfredo Falcone; Stefano Cascinu
Epidermal growth factor receptor gene promoter methylation in primary colorectal tumors and corresponding metastatic sites: a new perspective for an "old" therapeutic target.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2009;31(6):417-23.
2009: Rossana Berardi; Giovanna Mantello; MARIO SCARTOZZI; Stefano Del Prete; Gabriele Luppi; Roberto Martinelli; Marco Fumagalli; Filippo Grillo Ruggieri; Italo Bearzi; Alessandra Mandolesi; Cristina Marmorale; Stefano Cascinu
Locally advanced rectal cancer patients receiving radio-chemotherapy: a novel clinical-pathologic score correlates with global outcome.
International journal of radiation oncology, biology, physics 2009;75(5):1437-43.
2009: Rossana Berardi; Elena Maccaroni; Azzurra Onofri; Riccardo Giampieri; Mirco Pistelli; Alessandro Bittoni; MARIO SCARTOZZI; Chiara Pierantoni; Alessandra Mandolesi; Italo Bearzi; Stefano Cascinu
Locally advanced rectal cancer: from molecular profiling to clinical practice. A literature review: Part 2.
Expert opinion on pharmacotherapy 2009;10(15):2467-78.
2009: Rossana Berardi; Elena Maccaroni; Azzurra Onofri; Riccardo Giampieri; Alessandro Bittoni; Mirco Pistelli; MARIO SCARTOZZI; Chiara Pierantoni; Maristella Bianconi; Stefano Cascinu
Multidisciplinary treatment of locally advanced rectal cancer: a literature review. Part 1.
Expert opinion on pharmacotherapy 2009;10(14):2245-58.
2009: MARIO SCARTOZZI; Alessandro Bittoni; Mirco Pistelli; Eva Galizia; Rossana Berardi; Riccardo Giampieri; Luca Faloppi; Stefano Cascinu
Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives.
Cancer treatment reviews 2009;35(5):451-62.
2009: Fotios Loupakis; Luca Pollina; Irene Stasi; Annamaria Ruzzo; MARIO SCARTOZZI; Daniele Santini; Gianluca Masi; Graziano Francesco; Chiara Cremolini; Eliana Rulli; Emanuele Canestrari; Niccola Funel; Gaia Schiavon; Iacopo Petrini; Mauro Magnani; Giuseppe Tonini; Daniela Campani; Irene Floriani; Stefano Cascinu; Alfredo Falcone
PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(16):2622-9.
2009: Stefano Cascinu; S Jelic
Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20 Suppl 4():37-40.
2009: Marcello Tiseo; Cesare Gridelli; Stefano Cascinu; Lucio Crinò; Franco Vito Piantedosi; Francesco Grossi; Alba A Brandes; Roberto Labianca; Salvatore Siena; Domenico Amoroso; Ornella Belvedere; Brunello Valentino; alessandra bearz; Paola Venturino; Andrea Ardizzoni
An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): data report from Italy.
Lung cancer (Amsterdam, Netherlands) 2009;64(2):199-206.
2009: Marc Peeters; Salvatore Siena; Eric Van Cutsem; Alberto Sobrero; Alain Hendlisz; Stefano Cascinu; Haralabos Kalofonos; Giovanna Devercelli; Michael Wolf; Rafael G Amado
Association of progression-free survival, overall survival, and patient-reported outcomes by skin toxicity and KRAS status in patients receiving panitumumab monotherapy.
Cancer 2009;115(7):1544-54.
2009: Rossana Berardi; Lorena Verdecchia; Marzia Di Pietro Paolo; Riccardo Giampieri; MARIO SCARTOZZI; Chiara Pierantoni; Maristella Bianconi; Paola Mazzanti; Stefano Cascinu
Women and lung cancer: clinical and molecular profiling as a determinate for treatment decisions: a literature review.
Critical reviews in oncology/hematology 2009;69(3):223-36.
2009: MARIO SCARTOZZI; Italo Bearzi; Alessandra Mandolesi; Chiara Pierantoni; Fotios Loupakis; alberto zaniboni; Francesca Negri; Antonello Quadri; Fausto Zorzi; Eva Galizia; Rossana Berardi; Tommasina Biscotti; Roberto Labianca; Gianluca Masi; Alfredo Falcone; Stefano Cascinu
Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis.
BMC cancer 2009;9():303.
2009: Cristina Gagliardi; Anna Vespa; Roberta Papa; Carlo Mariotti; Stefano Cascinu; Simonetta Rossini
Social support networks and depression of women suffering from early-stage breast cancer: a case control study.
Journal of psychosocial oncology 2009;27(2):216-29.
2008: Valentina Guarneri; Antonio Frassoldati; Paolo Bruzzi; Roberto D'Amico; Maurizio Belfiglio; Annamaria Molino; Oscar Bertetto; Stefano Cascinu; Francesco Cognetti; Angelo Di Leo; Paolo Pronzato; Lucio Crinó; Biagio Agostara; PierFranco Conte
Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278).
Clinical breast cancer 2008;8(5):453-6.
2008: Michele Reni; R Berardi; A Mambrini; L Pasetto; Stefano Cereda; V D Ferrari; Stefano Cascinu; maurizio cantore; E Mazza; S Grisanti
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma.
Cancer chemotherapy and pharmacology 2008;62(4):673-8.
2008: Chiara Braconi; Raffaella Bracci; Italo Bearzi; Francesca Bianchi; S Sabato; Alessandra Mandolesi; Laura Belvederesi; Stefano Cascinu; N Valeri; Riccardo Cellerino
Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(7):1293-8.
2008: Chiara Pierantoni; Alessandra Pagliacci; MARIO SCARTOZZI; Rossana Berardi; Maristella Bianconi; Stefano Cascinu
Pancreatic cancer: progress in cancer therapy.
Critical reviews in oncology/hematology 2008;67(1):27-38.
2008: C Braconi; Raffaella Bracci; Italo Bearzi; Francesca Bianchi; A Costagliola; Romina Catalani; A Mandolesi; R Ranaldi; Eva Galizia; Stefano Cascinu; G Rossi; L Giustini; L Latini; N Valeri; Riccardo Cellerino
KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(4):706-10.
2008: F V Negri; Nicoletta Campanini; Roberta Camisa; Francesca Pucci; S Bui; G Ceccon; R Martinelli; M Fumagalli; P L Losardo; Pellegrino Crafa; Cesare Bordi; Stefano Cascinu; Andrea Ardizzoni
Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy.
British journal of cancer 2008;98(1):143-7.
2008: Stefano Cascinu; Rossana Berardi; Stefania Salvagni; Giordano D Beretta; Vincenzo Catalano; Francesca Pucci; Alberto Sobrero; Pierosandro Tagliaferri; Roberto Labianca; MARIO SCARTOZZI; F Crocicchio; E Mari; Andrea Ardizzoni
A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation.
British journal of cancer 2008;98(1):71-6.
2008: Eric Van Cutsem; Cornelius Van de Velde; A Roth; Florian Lordick; Claus-Henning Köhne; Stefano Cascinu; Matti Aapro
Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
European journal of cancer (Oxford, England : 1990) 2008;44(2):182-94.
2008: Stefano Cascinu; Rossana Berardi; Roberto Labianca; Salvatore Siena; Alfredo Falcone; Enrico Aitini; Sandro Barni; Francesco Di Costanzo; Elisa Dapretto; Giuseppe Tonini; Chiara Pierantoni; Salvatore Artale; Silvia Rota; Irene Floriani; MARIO SCARTOZZI; alberto zaniboni
Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial.
The lancet oncology 2008;9(1):39-44.
2007: Stefano Cascinu; MARIO SCARTOZZI; Giovanna Carbonari; Chiara Pierantoni; Lorena Verdecchia; Cinzia Mariani; Michela Squadroni; Stefania Antognoli; Rosa Rita Silva; Riccardo Giampieri; Rossana Berardi
COX-2 and NF-KB overexpression is common in pancreatic cancer but does not predict for COX-2 inhibitors activity in combination with gemcitabine and oxaliplatin.
American journal of clinical oncology 2007;30(5):526-30.
2007: Filippo Grillo Ruggieri; Giovanna Mantello; Rossana Berardi; Massimo Cardinali; Francesco Fenu; Giuseppina Iovini; Maria Montisci; Letizia Fabbietti; Cristina Marmorale; Mario Guerrieri; Vittorio Saba; Italo Bearzi; Rodolfo Mattioli; Maurizio Bonsignori; Stefano Cascinu
Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy.
Diseases of the colon and rectum 2007;50(10):1594-603.
2007: mario mandala; Michele Reni; Stefano Cascinu; S Barni; Irene Floriani; Stefano Cereda; R Berardi; Stefania Mosconi; Valter Torri; Roberto Labianca
Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(10):1660-5.
2007: MARIO SCARTOZZI; Italo Bearzi; Chiara Pierantoni; Alessandra Mandolesi; Fotios Loupakis; alberto zaniboni; Vincenzo Catalano; Antonello Quadri; Fausto Zorzi; Rossana Berardi; Tommasina Biscotti; Roberto Labianca; Alfredo Falcone; Stefano Cascinu
Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3930-5.
2007: Andrea Sartore-Bianchi; Mauro Moroni; Silvio Veronese; Carlo Carnaghi; Emilio Bajetta; Gabriele Luppi; Alberto Sobrero; Carlo Barone; Stefano Cascinu; Giuseppe Colucci; Enrico Cortesi; Michele Nichelatti; Marcello Gambacorta; Salvatore Siena
Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3238-45.
2007: MARIO SCARTOZZI; Italo Bearzi; Rossana Berardi; Alessandra Mandolesi; Chiara Pierantoni; Stefano Cascinu
Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options.
British journal of cancer 2007;97(1):92-7.
2007: Stefano Cascinu; alberto zaniboni; MARIO SCARTOZZI; Fausto Meriggi
Molecular biology for stage II colorectal cancer: the jury is still out.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2861; author reply 2862-3.
2007: MARIO SCARTOZZI; Eva Galizia; Lorena Verdecchia; Rossana Berardi; Stefania Antognoli; Silvia Chiorrini; Stefano Cascinu
Chemotherapy for advanced gastric cancer: across the years for a standard of care.
Expert opinion on pharmacotherapy 2007;8(6):797-808.
2006: Andrea Bonetti; Stefano Cascinu; Alfredo Falcone; Evaristo Maiello; alberto zaniboni; Carlo Aschele
[Metastatic colorectal cancer: adjournments from ESMO 2006].
Tumori 2006;92(6):1-12.
2006: Rossana Berardi; Chiara Braconi; Giovanna Mantello; MARIO SCARTOZZI; S Del Prete; Gabriele Luppi; R Martinelli; M Fumagalli; Gianluca Valeri; Italo Bearzi; C Marmovale; F Grillö-Ruggieri; Stefano Cascinu
Anemia may influence the outcome of patients undergoing neo-adjuvant treatment of rectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1661-4.
2006: MARIO SCARTOZZI; Alfredo Falcone; Francesca Pucci; Chiara Braconi; Chiara Pierantoni; Luigi Cavanna; Vittorio Franciosi; Rossana Berardi; Giordano D Beretta; Gianluca Masi; Giacomo Allegrini; alberto zaniboni; Roberto Labianca; Stefano Cascinu
Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancer.
Tumori 2006;92(5):384-8.
2006: MARIO SCARTOZZI; Eva Galizia; Lorena Verdecchia; Rossana Berardi; Graziano Francesco; Vincenzo Catalano; Paolo Giordani; Davide Mari; Rosa Rita Silva; Cristina Marmorale; C Zingaretti; Stefano Cascinu
Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients.
British journal of cancer 2006;95(4):445-9.
2006: Nicola Battelli; Cristian Massacesi; Chiara Braconi; Alberta Pilone; Luigi Manzione; Angelo Dinota; Stefano Cobelli; Alberto Scanni; Fabio Sturba; Giusi Giacomini; Donatella Morale; Francesca Giorgi; Diego Tummarello; Stefano Cascinu
Paclitaxel and epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil for patients with stage IIIC breast cancer with ten or more involved axillary lymph nodes.
American journal of clinical oncology 2006;29(4):380-4.
2006: Rossana Berardi; Berardi Rossana; MARIO SCARTOZZI; Scartozzi Mario; Federica Freddari; Freddari Federica; Michela Squadroni; Squadroni Michela; Alfredo Santinelli; Santinelli Alfredo; Italo Bearzi; Bearzi Italo; Guidalberto Fabris; Fabris Guidalberto; Stefano Cascinu; Cascinu Stefano
Biliary tract cancers: molecular profiling as a tool for treatment decisions. A literature review.
Cancer treatment reviews 2006;32(5):333-47.
2006: Andrea Bonetti; Stefano Cascinu; Alfredo Falcone; alberto zaniboni
[ASCO 2006 Annual Meeting, Atlanta, June 2-6, 2006. Focus on gastrointestinal tumors].
Tumori 2006;92(4):suppl 10-43.
2006: MARIO SCARTOZZI; Vittorio Franciosi; Nicoletta Campanini; Giovanni Benedetti; Fausto Barbieri; Giulio Rossi; Rossana Berardi; Roberta Camisa; Rosa Rita Silva; Alfredo Santinelli; Andrea Ardizzoni; Lucio Crinò; Guido Rindi; Stefano Cascinu
Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients.
Lung cancer (Amsterdam, Netherlands) 2006;53(1):103-9.
2006: Stefano Cascinu; Lorena Verdecchia; N Valeri; Rossana Berardi; MARIO SCARTOZZI
New target therapies in advanced pancreatic cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 5():v148-52.
2006: Stefano Pergolizzi; Vincenzo Adamo; Elvio G Russi; Anna Santacaterina; Roberto Maisano; Gianmauro Numico; Carmela Palazzolo; Francesco Ferraù; Nicola Settineri; Giuseppe Altavilla; Andrea Girlando; Pietro Spadaro; Stefano Cascinu
Prospective multicenter study of combined treatment with chemotherapy and radiotherapy in breast cancer women with the rare clinical scenario of ipsilateral supraclavicular node recurrence without distant metastases.
International journal of radiation oncology, biology, physics 2006;65(1):25-32.
2006: Annamaria Ruzzo; Graziano Francesco; Kazuyuki Kawakami; Go Watanabe; Daniele Santini; Vincenzo Catalano; Renato Bisonni; Emanuele Canestrari; Rita Ficarelli; Ettore Tito Menichetti; Davide Mari; Enrica Testa; Rosarita Silva; Bruno Vincenzi; Paolo Giordani; Stefano Cascinu; Lucio Giustini; Giuseppe Tonini; Mauro Magnani
Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1883-91.
2006: MARIO SCARTOZZI; Chiara Pierantoni; Rossana Berardi; Stefania Antognoli; Italo Bearzi; Stefano Cascinu
Epidermal growth factor receptor: a promising therapeutic target for colorectal cancer.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2006;28(2):61-8.
2006: MARIO SCARTOZZI; Chiara Pierantoni; Rossana Berardi; Michela Squadroni; Stefano Cascinu
Anti-EGFR strategies as an incremental step for the treatment of colorectal cancer patients: moving from scientific evidence to clinical practice.
Expert opinion on therapeutic targets 2006;10(2):281-7.
2006: Marina E Cazzaniga; Luigi Dogliotti; Stefano Cascinu; Sandro Barni; Roberto Labianca; Silvana Chiara; Pier Franco Conte; Giampietro Gasparini; Lara Maria Pasetto; Valter Torri
Diagnosis, management and clinical outcome of bone metastases in breast cancer patients: results from a prospective, multicenter study.
Oncology 2006;71(5-6):374-81.
2006: Daniele Santini; Graziano Francesco; Vincenzo Catalano; Marisa Di Seri; Enrica Testa; Anna Maria Baldelli; Paolo Giordani; Annalisa La Cesa; Bruno Spalletta; Bruno Vincenzi; A Russo; Michele Caraglia; V Virzi; Stefano Cascinu; Giuseppe Tonini
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial.
BMC cancer 2006;6():125.
2005: Giovanna Mantello; Rossana Berardi; Massimo Cardinali; Letizia Fabbietti; Francesco Fenu; Maria Montisci; G Iovini; Stefano Delprete; Rodolfo Mattioli; Stefano Cascinu; Filippo Grillo Ruggieri
Feasibility of preoperative chemoradiation in rectal cancer patients aged 70 and older.
Journal of experimental & clinical cancer research : CR 2005;24(4):541-6.
2005: Rossana Berardi; G Grilli; E Romagnoli; T Saladino; Federica Freddari; T Tamburrano; Eva Galizia; G Carbonari; C Mariani; Chiara Braconi; Chiara Pierantoni; Nicola Battelli; MARIO SCARTOZZI; Stefano Cascinu
[Paraneoplastic syndromes: a review].
La Clinica terapeutica 2005;156(6):281-8.
2005: Antonino Musolino; Maria Michiara; Maria A Bella; Nadia Naldi; Paola Zanelli; Beatrice Bortesi; Marzia Capelletti; Linda Soldani; Roberta Camisa; Eugenia Martella; Vittorio Franciosi; Mario Savi; Tauro M Neri; Andrea Ardizzoni; Stefano Cascinu
Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study.
Tumori 2005;91(6):505-12.
2005: Rossana Berardi; Tiziana Saladino; Davide Mari; Rosa Rita Silva; MARIO SCARTOZZI; Lorena Verdecchia; Azzurra Onofri; Stefano Cascinu
Elderly patients with advanced colorectal cancer: tolerability and activity of chemotherapy.
Tumori 2005;91(6):463-6.
2005: Teresa Catalano; Maria Cristina Curia; Gitana Aceto; Fabio Verginelli; Stefano Cascinu; Alessandro Cama; Renato Mariani-Costantini; Diana Teti; Pasquale Battista
Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
Oncology reports 2005;14(3):625-31.
2005: Rossana Berardi; Alessandro Brunelli; T Tamburrano; Lorena Verdecchia; A Onofri; L Zuccatosta; S Gasparini; Alfredo Santinelli; MARIO SCARTOZZI; Gianluca Valeri; Andrea Giovagnoni; Gian Marco Giuseppetti; Guidalberto Fabris; Cristina Marmorale; Aroldo Fianchini; Stefano Cascinu
Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers.
Lung cancer (Amsterdam, Netherlands) 2005;49(3):371-6.
2005: Annamaria Ruzzo; Graziano Francesco; Francesca Pizzagalli; Daniele Santini; V Battistelli; Simona Panunzi; Emanuele Canestrari; Vincenzo Catalano; Bostjan Humar; Rita Ficarelli; Italo Bearzi; Stefano Cascinu; N Naldi; Enrica Testa; Mauro Magnani
Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(6):887-92.
2005: Kazuyuki Kawakami; Graziano Francesco; Go Watanabe; Annamaria Ruzzo; Daniele Santini; Vincenzo Catalano; Renato Bisonni; Federica Arduini; Italo Bearzi; Stefano Cascinu; Pietro Muretto; Giuseppe Perrone; Carla Rabitti; Lucio Giustini; Giuseppe Tonini; Francesca Pizzagalli; Mauro Magnani
Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(10):3778-83.
2005: MARIO SCARTOZZI; Rossana Berardi; Chiara Pierantoni; Stefano Cascinu
Pre-operative treatment modalities in gastric cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 4():iv106-109.
2005: Andrea Giovagnoni; Letizia Ottaviani; Anna Mensà; Martina Durastanti; Irene Floriani; Stefano Cascinu
Evidence Based Medicine (EBM) and Evidence Based Radiology (EBR) in the follow-up of the patients after surgery for lung and colon-rectal carcinoma.
La Radiologia medica 2005;109(4):345-57.
2005: Graziano Francesco; Annamaria Ruzzo; Daniele Santini; Bostjan Humar; Giuseppe Tonini; Vincenzo Catalano; Rossana Berardi; Francesca Pizzagalli; Federica Arduini; Italo Bearzi; MARIO SCARTOZZI; Stefano Cascinu; Enrica Testa; Rita Ficarelli; Mauro Magnani
Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2339-45.
2005: MARIO SCARTOZZI; Eva Galizia; Graziano Francesco; Vincenzo Catalano; Rossana Berardi; Anna Maria Baldelli; Enrica Testa; Davide Mari; Rosa Rita Silva; Stefano Cascinu
Over-DI dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients.
British journal of cancer 2005;92(6):1051-4.
2005: Giorgio Cocconi; Alessandro Gamboni; Donatello Gasparro; Francesco Leonardi; Stefania Salvagni; Giovanna Vasini; Pietro Larini; Carla Marcato; Roberta Camisa; Stefano Cascinu
Hepatic artery administration of docetaxel in liver metastases from breast carcinoma: a feasibility study.
Tumori 2005;91(2):121-5.
2005: MARIO SCARTOZZI; Alberto Sobrero; G Gasparini; Rossana Berardi; Vincenzo Catalano; Graziano Francesco; Sandro Barni; alberto zaniboni; Giordano D Beretta; Roberto Labianca; Stefano Cascinu
The role of 5-fluorouracil (5-FU) reintroduction with irinotecan or oxaliplatin in truly 5-FU-refractory advanced colorectal cancer patients.
Oncology 2005;68(2-3):212-6.
2005: Rossana Berardi; Lorena Verdecchia; MARIO SCARTOZZI; Stefano Cascinu
New frontiers in the neoadjuvant therapy of pancreatic adenocarcinoma: apart from therapeutical protocols.
JOP : Journal of the pancreas 2005;6(1 Suppl):118-21.
2004: Graziano Francesco; Kazuyuki Kawakami; Go Watanabe; Annamaria Ruzzo; Bostjan Humar; Daniele Santini; Vincenzo Catalano; Rita Ficarelli; Tony Merriman; Simona Panunzi; Enrica Testa; Stefano Cascinu; Italo Bearzi; Giuseppe Tonini; Mauro Magnani
Association of thymidylate synthase polymorphisms with gastric cancer susceptibility.
International journal of cancer. Journal international du cancer 2004;112(6):1010-4.
2004: MARIO SCARTOZZI; Italo Bearzi; Rossana Berardi; Alessandra Mandolesi; Guidalberto Fabris; Stefano Cascinu
Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(23):4772-8.
2004: Eva Galizia; Rossana Berardi; MARIO SCARTOZZI; Stefano Cascinu
A cost-benefit analysis of chemotherapy for gastric cancer.
Expert opinion on pharmacotherapy 2004;5(10):2109-14.
2004: Stefano Cascinu
[Some aspects to discuss in the care of the elderly oncologic patient].
Tumori 2004;90(5):9-13.
2004: MARIO SCARTOZZI; Eva Galizia; Federica Freddari; Rossana Berardi; Riccardo Cellerino; Stefano Cascinu
Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches.
Cancer treatment reviews 2004;30(5):451-9.
2004: Stefano Cascinu; Rossana Berardi
[The DUR studies: colon cancer adjuvants].
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2004;3(4):S88.
2004: Graziano Francesco; Alessandra Mandolesi; Annamaria Ruzzo; Italo Bearzi; Enrica Testa; Federica Arduini; Rosarita Silva; Pietro Muretto; Davide Mari; Rossana Berardi; MARIO SCARTOZZI; Vittorio Lai; Stefano Cascinu; Mauro Magnani
Predictive and prognostic role of E-cadherin protein expression in patients with advanced gastric carcinomas treated with palliative chemotherapy.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2004;25(3):106-10.
2004: Maria Antonietta Perrone; Antonino Musolino; Maria Michiara; Beatrice Di Blasio; Maria A Bella; Vittorio Franciosi; Giorgio Cocconi; Roberta Camisa; Renata Todeschini; Stefano Cascinu
Early detection of recurrences in the follow-up of primary breast cancer in an asymptomatic or symptomatic phase.
Tumori 2004;90(3):276-9.
2004: Filippo de Braud; Stefano Cascinu; Gemma Gatta
Cancer of pancreas.
Critical reviews in oncology/hematology 2004;50(2):147-55.
2004: Stefano Cascinu; MARIO SCARTOZZI; Roberto Labianca; Vincenzo Catalano; Rosa Rita Silva; Sandro Barni; alberto zaniboni; A D'Angelo; Stefania Salvagni; Giancarlo Martignoni; Giordano D Beretta; Graziano Francesco; Rossana Berardi; Vittorio Franciosi
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
British journal of cancer 2004;90(8):1521-5.
2004: Graziano Francesco; Federica Arduini; Annamaria Ruzzo; Italo Bearzi; Bostjan Humar; Helen More; Rosarita Silva; Pietro Muretto; Parry Guilford; Enrica Testa; Davide Mari; Mauro Magnani; Stefano Cascinu
Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(8):2784-9.
2004: Rossana Berardi; MARIO SCARTOZZI; Emanuela Romagnoli; Stefania Antognoli; Stefano Cascinu
Gastric cancer treatment: a systematic review.
Oncology reports 2004;11(4):911-6.
2004: Federica Freddari; Rossana Berardi; MARIO SCARTOZZI; Stefano Cascinu
[Non-small cell lung carcinoma: pathology, biology and prognosis].
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2004;3(2):S3-4.
2004: Graziano Francesco; Federica Arduini; Annamaria Ruzzo; Alessandra Mandolesi; Italo Bearzi; Rosarita Silva; Pietro Muretto; Enrica Testa; Davide Mari; Mauro Magnani; MARIO SCARTOZZI; Stefano Cascinu
Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(3):489-92.
2003: Giorgio Cocconi; Vittorio Franciosi; Anna Dodero; Alessandra Bologna; Giovanna Vasini; Vincenzo De Lisi; Beatrice Di Blasio; Guido Ceci; Roberta Camisa; Stefano Cascinu
P-CHOP: cisplatin (P) added to the standard CHOP regimen as first-line treatment for aggressive non-Hodgkin lymphoma: a single-institution phase II study.
American journal of clinical oncology 2003;26(6):535-42.
2003: Michele Gaeta; Alfredo Blandino; Stefano Pergolizzi; Silvio Mazziotti; Rosario Caruso; Mario Barone; Stefano Cascinu
Patterns of recurrence of bronchioloalveolar cell carcinoma after surgical resection: a radiological, histological, and immunohistochemical study.
Lung cancer (Amsterdam, Netherlands) 2003;42(3):319-26.
2003: Cecilia Bozzetti; Nicola Personeni; Rita Nizzoli; Annamaria Guazzi; Marcella Flora; Cristina Bassano; Francesca Negri; Eugenia Martella; Nadia Naldi; Vittorio Franciosi; Stefano Cascinu
HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma.
Cancer 2003;99(5):310-5.
2003: Graziano Francesco; Daniele Santini; Enrica Testa; Vincenzo Catalano; Giordano D Beretta; Stefania Mosconi; Giuseppe Tonini; Vittorio Lai; Roberto Labianca; Stefano Cascinu
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer.
British journal of cancer 2003;89(8):1428-32.
2003: Rossana Berardi; Andrea Piga; Franca Pulita; Emanuela Romagnoli; Debora Pietroselli; Flavia Carle; Stefano Cascinu; Riccardo Cellerino
Effective prevention of 5-fluorouracil-induced superficial phlebitis by ketoprofen lysine salt gel.
The American journal of medicine 2003;115(5):415-7.
2003: Graziano Francesco; Stefano Cascinu
Treatment of metastatic colorectal cancer with monoclonal antibody to vascular endothelial growth factor: does the metastatic site make the difference?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3542-3; author reply 3543.
2003: Rossana Berardi; MARIO SCARTOZZI; Eva Galizia; Stefano Cascinu
Adjuvant chemotherapy in gastric cancer. The Italian experience and review of the literature.
I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] 2003;2(5):S45-7.
2003: Stefano Cascinu; Paolo Giordani; Romina Agostinelli; Giampietro Gasparini; Sandro Barni; Giordano D Beretta; Franca Pulita; Laura Iacorossi; Domenico Gattuso; Marzia Mare; Stefania Munaò; Roberto Labianca; Renata Todeschini; Roberta Camisa; Riccardo Cellerino; Giuseppe Catalano
Pain and its treatment in hospitalized patients with metastatic cancer.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2003;11(9):587-92.
2003: Graziano Francesco; Stefano Cascinu
Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(7):1026-38.
2003: Vittorio Franciosi; Roberto Barbieri; Enrico Aitini; Giovanna Vasini; Gian Carlo Cacciani; Roberto Capra; Roberta Camisa; Stefano Cascinu
Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands) 2003;41(1):101-6.
2003: Stefano Cascinu; Graziano Francesco; Vincenzo Catalano; Sandro Barni; Paolo Giordani; Anna Maria Baldelli; Maria Pia Staccioli; Cristina Rossi; Angelo Brenna; Andrea Valenti; Pietro Muretto; Giuseppe Catalano
Vascular endothelial growth factor and p53 expressions in liver and abdominal metastases from colon cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2003;24(2):77-81.
2003: Rita Nizzoli; Cecilia Bozzetti; Pellegrino Crafa; Nadia Naldi; Annamaria Guazzi; Beatrice Di Blasio; Roberta Camisa; Stefano Cascinu
Immunocytochemical evaluation of HER-2/neu on fine-needle aspirates from primary breast carcinomas.
Diagnostic cytopathology 2003;28(3):142-6.
2003: Alessandro Morabito; Gianfranco Filippelli; Sergio Palmeri; Stefano Cascinu; Francesco Ferraù; Vittorina Zagonel; Domenico Gattuso; Vincenzo Catalano; Barbara Capaccetti; Vittorio Franciosi; Vincenzo Accurso; Fedele Scinto; Giampietro Gasparini
The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study.
Breast cancer research and treatment 2003;78(1):29-36.
2003: Stefano Cascinu; Roberto Labianca; Vincenzo Catalano; Sandro Barni; Francesco Ferraù; Giordano D Beretta; Luciano Frontini; P Foa; Gianfranco Pancera; Domenico Priolo; Graziano Francesco; Marzia Mare; Giuseppe Catalano
Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):205-8.
2003: Stefano Cascinu; Vincenzo Catalano; Andrea Piga; Rodolfo Mattioli; Massimo Marcellini; Amedeo Pancotti; Romeo Bascioni; Umberto Torresi; Rosa Rita Silva; Vitaliano Pieroni; Francesca Giorgi; Giuseppe Catalano; Riccardo Cellerino
The role of levamisole in the adjuvant treatment of stage III colon cancer patients: a randomized trial of 5-fluorouracil and levamisole versus 5-fluorouracil alone.
Cancer investigation 2003;21(5):701-7.
2003: Vittorio Franciosi; Marco Fumagalli; Luciana Biscari; Roberto Martinelli; Teore Ferri; Maria A Bella; Guido Ceci; Vincenzo Delisi; Beatrice Di Blasio; Francesco Leonardi; Maria Michiara; Francesca Pucci; Giovanna Vasini; Roberta Camisa; Stefano Cascinu
Compliance and outcomes in locally advanced head and neck cancer patients treated with alternating chemo-radiotherapy in clinical practice.
Tumori 2003;89(1):20-5.
2003: Cecilia Bozzetti; Annamaria Guazzi; Rita Nizzoli; Nadia Naldi; Vittorio Franciosi; Stefano Cascinu
Determination of biological parameters on fine-needle aspirates from non-small cell lung cancer.
Methods in molecular medicine 2003;75():405-20.
2002: Carlo Aschele; Domizia Debernardis; Roberto Bandelloni; Stefano Cascinu; Vincenzo Catalano; Paolo Giordani; Sandro Barni; Daniele Turci; G Drudi; Sara Lonardi; Luigi Gallo; F Maley; Silvio Monfardini
Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(12):1882-92.
2002: Bostjan Humar; Graziano Francesco; Stefano Cascinu; Vincenzo Catalano; Annamaria Ruzzo; Mauro Magnani; Tumi Toro; Tudor Burchill; Matthias E Futschik; Tony Merriman; Parry Guilford
Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer.
Oncogene 2002;21(53):8192-5.
2002: Stefano Cascinu; Roberta Camisa; Alessandro D'Angelo; Stefania Salvagni
[Evolution of the parameters indicating response to drug therapy: from regression to complete control of the disease and the symptoms].
Tumori 2002;88(6):A7-9.
2002: Cecilia Bozzetti; Rita Nizzoli; Annamaria Guazzi; Marcella Flora; Cristina Bassano; Pellegrino Crafa; Nadia Naldi; Stefano Cascinu
HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1398-403.
2002: Stefano Cascinu; Vincenzo Catalano; Luigi Cordella; Roberto Labianca; Paolo Giordani; Anna Maria Baldelli; Giordano D Beretta; Emilio Ubiali; Giuseppe Catalano
Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(16):3478-83.
2002: Stefano Cascinu; Graziano Francesco; Francesco Ferraù; Vincenzo Catalano; Cristian Massacesi; Daniele Santini; Rosa Rita Silva; Sandro Barni; alberto zaniboni; Nicola Battelli; S Siena; Paolo Giordani; Davide Mari; Anna Maria Baldelli; Stefania Antognoli; Roberto Maisano; Domenico Priolo; MA Pessi; Giuseppe Tonini; S Rota; Roberto Labianca
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(5):716-20.
2002: Stefano Cascinu; Graziano Francesco; Vincenzo Catalano; Maria Pia Staccioli; Maria C E Rossi; Anna Maria Baldelli; Sandro Barni; Angelo Brenna; S Secondino; Pietro Muretto; Giuseppe Catalano
An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation.
British journal of cancer 2002;86(5):744-9.
2002: Paolo Lippe; Rosa R Silva; Luciano Giuliodori; Maria C Monterubbianesi; Rodolfo Mattioli; Cristian Massacesi; Stefano Cascinu; Diego Tummarello; Riccardo Cellerino
Clinical benefit of gemcitabine-cisplatin in advanced non-small cell lung cancer elderly patients.
Anticancer research 2002;22(2B):1053-9.
2002: Cecilia Bozzetti; Rita Nizzoli; Annamaria Guazzi; Vittorio Franciosi; Leonardo Cattelani; Pellegrino Crafa; Nadia Naldi; Stefano Cascinu
Biological parameters on computed tomography guided fine needle aspiration biopsy from peripheral primary non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2002;35(3):243-7.
2002: Stefano Cascinu; Anna Maria Baldelli; Vincenzo Catalano; Paolo Giordani; Giordano D Beretta; Rosa Rita Silva; G Gasparini; Davide Mari; Roberto Maisano; Stefania Salvagni; Sandro Barni; Roberto Labianca; Luciano Frontini; C Curti; Giuseppe Catalano
Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: a low cost effective regimen.
British journal of cancer 2002;86(2):213-7.
2001: Graziano Francesco; Vincenzo Catalano; Anna Maria Baldelli; Stefano Cascinu
Prognostic biomarkers in resected colorectal cancer: implications for adjuvant chemotherapy.
Expert review of anticancer therapy 2001;1(2):247-57.
2001: Stefano Pergolizzi; Nicola Settineri; Anna Santacaterina; Pietro Spadaro; Roberto Maisano; Nicola Caristi; Vincenzo Adamo; de renzis costantino; Mario Mesiti; Stefano Cascinu
Ipsilateral supraclavicular lymph nodes metastases from breast cancer as only site of disseminated disease. Chemotherapy alone vs. induction chemotherapy to radical radiation therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(8):1091-5.
2001: Vincenzo Catalano; Anna Maria Baldelli; Paolo Giordani; Stefano Cascinu
Molecular markers predictive of response to chemotherapy in gastrointestinal tumors.
Critical reviews in oncology/hematology 2001;38(2):93-104.
2001: Stefano Cascinu; Graziano Francesco; M Valentini; Vincenzo Catalano; Paolo Giordani; Maria Pia Staccioli; C Rossi; Anna Maria Baldelli; C Grianti; Pietro Muretto; Giuseppe Catalano
Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(2):239-44.
2001: Stefano Cascinu; Graziano Francesco; Sandro Barni; Roberto Labianca; Giuseppe Comella; Rossana Casaretti; Luciano Frontini; Vincenzo Catalano; Anna Maria Baldelli; Giuseppe Catalano
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.
British journal of cancer 2001;84(4):470-4.
2001: Marcello Aragona; Stefania Panetta; AM Silipigni; Domenico Romeo; G Pastura; Mario Mesiti; Stefano Cascinu; Francesco La Torre
Nerve growth factor receptor immunoreactivity in breast cancer patients.
Cancer investigation 2001;19(7):692-7.
2001: Graziano Francesco; Stefano Cascinu; Maria Pia Staccioli; Vincenzo Catalano; Maria C E Rossi; Anna Maria Baldelli; Paolo Giordani; Pietro Muretto; Giuseppe Catalano
Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer.
BMC cancer 2001;1():9.
2001: Stefano Cascinu; Stefania Salvagni; Roberta Camisa; Donatello Gasparro; L Biscari; Francesca Pucci; Francesco Leonardi; Vittorio Franciosi
[Colonic cancer. Adjuvant therapy: the Italian experience].
Tumori 2001;87(1 Suppl 1):S83-4.
2001: Stefano Cascinu; E Del Ferro; M Ligi; Maria Pia Staccioli; Paolo Giordani; Vincenzo Catalano; Romina Agostinelli; Pietro Muretto; Giuseppe Catalano
Inhibition of vascular endothelial growth factor by octreotide in colorectal cancer patients.
Cancer investigation 2001;19(1):8-12.
2001: Stefano Cascinu; Vincenzo Catalano; Paolo Giordani; Anna Maria Baldelli; Romina Agostinelli; Giuseppe Catalano
Gastrointestinal cancer refractory to chemotherapy: a role for octreotide?
Chemotherapy 2001;47 Suppl 2():127-33.
2000: Stefania Mosconi; Stefano Cascinu; alberto zaniboni; Vincenzo Catalano; Paolo Giordani; Giordano D Beretta; Giancarlo Martignoni; Gianfranco Pancera; Anna Maria Baldelli; Paola Poletti; C Curti; Roberto Labianca
The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial.
Tumori 2000;86(6):465-9.
2000: Stefano Cascinu; Luciano Frontini; Roberto Labianca; Vincenzo Catalano; Sandro Barni; claudio graiff; G Picone; E Farinati; S Zonato; MA Pessi; C Curti; Giuseppe Catalano
A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(10):1309-11.
2000: Graziano Francesco; Vincenzo Catalano; Anna Maria Baldelli; Paolo Giordani; Enrica Testa; Vittorio Lai; Giuseppe Catalano; Nicola Battelli; Stefano Cascinu
A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(10):1263-6.
2000: Stefano Cascinu; Graziano Francesco; Vincenzo Catalano; M Valentini; Maria C E Rossi; Anna Maria Baldelli; R Ghiselli; V Saba; Paolo Giordani; Giuseppe Catalano
Prognostic value of S-phase fraction in T3N0M0 gastric cancer. Implications for adjuvant chemotherapy.
Anticancer research 2000;20(5C):3839-42.
2000: Marcello Aragona; Carmelo Antonio Buda; Stefania Panetta; M Morelli; A Giudice; F L Campagna; ANTONIO PONTORIERO; Stefano Cascinu; Francesco La Torre
Immunohistochemical telomeric-repeat binding factor-1 expression in gastrointestinal tumors.
Oncology reports 2000;7(5):987-90.
2000: Stefano Cascinu; Vincenzo Catalano; Carlo Aschele; Sandro Barni; Domizia Debernardis; Luigi Gallo; Roberto Bandelloni; Maria Pia Staccioli; Anna Maria Baldelli; Angelo Brenna; Andrea Valenti; Pietro Muretto; Giuseppe Catalano
Immunohistochemical determination of p53 protein does not predict clinical response in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil-leucovorin combination.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(8):1053-6.
2000: Stefano Cascinu; Maria Pia Staccioli; Giampietro Gasparini; Paolo Giordani; Vincenzo Catalano; R Ghiselli; C Rossi; Anna Maria Baldelli; Graziano Francesco; V Saba; Pietro Muretto; Giuseppe Catalano
Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2803-7.
2000: Stefano Cascinu; S Munaó; Marzia Mare; P Amadio; E Crucitta; G Picone
[Tolerance profile of platinum compounds].
Tumori 2000;86(3 Suppl):S54-5.
2000: Stefano Cascinu; Graziano Francesco; Vincenzo Catalano; Maria Pia Staccioli; Sandro Barni; Paolo Giordani; Maria C E Rossi; Anna Maria Baldelli; Pietro Muretto; Andrea Valenti; Giuseppe Catalano
Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors.
Clinical & experimental metastasis 2000;18(8):651-5.
2000: Stefano Cascinu; M Ligi; E Del Ferro; G Foglietti; P Cioccolini; Maria Pia Staccioli; A Carnevali; M B Luigi Rocchi; Paolo Alessandroni; Paolo Giordani; Vincenzo Catalano; V Polizzi; Romina Agostinelli; Pietro Muretto; Giuseppe Catalano
Effects of calcium and vitamin supplementation on colon cell proliferation in colorectal cancer.
Cancer investigation 2000;18(5):411-6.
2000: Stefano Cascinu; E Bichisao; D Amadori; Vittorio Silingardi; Paolo Giordani; E Sansoni; Gabriele Luppi; Vincenzo Catalano; Romina Agostinelli; Giuseppe Catalano
High-dose loperamide in the treatment of 5-fluorouracil-induced diarrhea in colorectal cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2000;8(1):65-7.
1999: Stefano Cascinu; Giampietro Gasparini; Vincenzo Catalano; Rosa Rita Silva; Gianfranco Pancera; Alessandro Morabito; Paolo Giordani; Domenico Gattuso; Giuseppe Catalano
A phase I-II study of gemcitabine and docetaxel in advanced pancreatic cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1377-9.
1999: Stefano Cascinu; Andrea Valenti; P Amadio; Marzia Mare; Stefania Munaò; E Crucitta; Massimo Raffaele; G Picone; Mario Mesiti; Giampietro Gasparini
Angiosuppression and chemotherapy: strategies aimed at their integration in cancer patients.
The International journal of biological markers 1999;14(4):239-42.
1999: Stefano Cascinu; Rosa Rita Silva; Roberto Labianca; Sandro Barni; Rodolfo Mattioli; Giancarlo Martignoni; Luciano Frontini; Giampietro Gasparini; Vincenzo Catalano; Anna Maria Baldelli; Luciano Giuliodori; Romina Agostinelli; Giuseppe Catalano
A phase II study of Tomudex alternated with methotrexate, 5-fluorouracil, leucovorin in first-line chemotherapy of metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(8):985-7.
1999: Stefano Cascinu; Carlo Aschele; Sandro Barni; Domizia Debernardis; C Baldo; G Tunesi; Vincenzo Catalano; Maria Pia Staccioli; Angelo Brenna; Pietro Muretto; Giuseppe Catalano
Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):1996-9.
1999: Stefano Cascinu; Rosa Rita Silva; Sandro Barni; Roberto Labianca; Luciano Frontini; Elena Piazza; Gianfranco Pancera; Paolo Giordani; Luciano Giuliodori; MA Pessi; V Fusco; G Luporini; Riccardo Cellerino; Giuseppe Catalano
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
British journal of cancer 1999;80(10):1595-8.
1999: Stefano Cascinu; Paolo Giordani; Vincenzo Catalano; Romina Agostinelli; Giuseppe Catalano
Resection-line involvement in gastric cancer patients undergoing curative resections: implications for clinical management.
Japanese journal of clinical oncology 1999;29(6):291-3.
1999: Sandro Barni; Stefano Cascinu; P Foa; Luciano Frontini; Roberto Labianca; G Luporini; Mario Mandalà; Giancarlo Martignoni; Gianfranco Pancera; Alberto Sobrero; alberto zaniboni
[Adjuvant therapy of colon cancer. State of the art and future perspectives].
Tumori 1999;85(3):A1-6.
1999: Paolo Lippe; Diego Tummarello; Maria C Monterubbianesi; Rosa Rita Silva; Luciano Giuliodori; Davide Mari; Antonio Santo; Felice Pasini; Gian Luigi Cetto; D Rossi; Emilio Porfiri; Stefano Cascinu; Riccardo Cellerino
Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(2):217-21.
1999: Stefano Cascinu; Luciano Frontini; Giuseppe Comella; Sandro Barni; Roberto Labianca; Nicola Battelli; Rossana Casaretti; S Zonato; M Pirovano; Giuseppe Catalano; Riccardo Cellerino
Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
British journal of cancer 1999;79(3-4):491-4.
1999: Stefano Cascinu; Graziano Francesco; Giuseppe Catalano
Chemotherapy for advanced pancreatic cancer: it may no longer be ignored.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(1):105-9.
1998: Stefano Cascinu; Graziano Francesco; E Del Ferro; Maria Pia Staccioli; M Ligi; A Carnevali; Pietro Muretto; Giuseppe Catalano
Expression of p53 protein and resistance to preoperative chemotherapy in locally advanced gastric carcinoma.
Cancer 1998;83(9):1917-22.
1998: Stefano Cascinu; M Ligi; Graziano Francesco; E Del Ferro; M Valentini; C Grianti; M Bartolucci; Giuseppe Catalano
S-phase fraction can predict event free survival in patients with pT2-T3N0M0 colorectal carcinoma: implications for adjuvant chemotherapy.
Cancer 1998;83(6):1081-5.
1998: Stefano Cascinu; Roberto Labianca; Graziano Francesco; Gianfranco Pancera; Sandro Barni; Luciano Frontini; G Luporini; Riccardo Cellerino; Giuseppe Catalano
Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
British journal of cancer 1998;78(3):390-3.
1998: Graziano Francesco; N Cardarelli; M Marcellini; Ettore Tito Menichetti; Giuseppe Catalano; Stefano Cascinu
A pilot clinical trial of postoperative intensive weekly chemotherapy using cisplatin, epi-doxorubicin, 5-fluorouracil, 6S-leucovorin, glutathione and filgrastim in patients with resected gastric cancer.
Tumori 1998;84(3):368-71.
1998: Graziano Francesco; Giuseppe Catalano; Stefano Cascinu
Chemotherapy for advanced pancreatic cancer: the history is changing.
Tumori 1998;84(3):308-11.
1998: Stefano Cascinu; Graziano Francesco; N Cardarelli; M Marcellini; Paolo Giordani; Ettore Tito Menichetti; Giuseppe Catalano
Phase II study of paclitaxel in pretreated advanced gastric cancer.
Anti-cancer drugs 1998;9(4):307-10.
1998: Stefano Cascinu; Graziano Francesco; Paolo Alessandroni; M Ligi; E Del Ferro; David Rossi; Rita Ficarelli; Giuseppe Catalano
Different doses of pamidronate in patients with painful osteolytic bone metastases.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1998;6(2):139-43.
1998: Stefano Cascinu; Vincenzo Catalano; Anna Maria Baldelli; MARIO SCARTOZZI; Nicola Battelli; Graziano Francesco; Riccardo Cellerino
Locoregional treatments of unresectable liver metastases from colorectal cancer.
Cancer treatment reviews 1998;24(1):3-14.
1997: Stefano Cascinu; Roberto Labianca; Paolo Alessandroni; M Marcellini; Rosa Rita Silva; Gianfranco Pancera; Enrica Testa; Giancarlo Martignoni; Sandro Barni; Luciano Frontini; alberto zaniboni; G Luporini; Riccardo Cellerino; Giuseppe Catalano
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(11):3313-9.
1997: Stefano Cascinu; E Del Ferro; M Ligi; Graziano Francesco; Giuseppe Catalano
The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer.
American journal of clinical oncology 1997;20(5):477-8.
1997: Stefano Cascinu; Rita Ficarelli; M A Safi; Graziano Francesco; Giuseppe Catalano; Riccardo Cellerino
A phase I study of paclitaxel and 5-fluorouracil in advanced gastric cancer.
European journal of cancer (Oxford, England : 1990) 1997;33(10):1699-702.
1997: Stefano Cascinu; E Del Ferro; C Grianti; M Ligi; R Ghiselli; G Foglietti; V Saba; F Lungarotti; Giuseppe Catalano
Inhibition of tumor cell kinetics and serum insulin growth factor I levels by octreotide in colorectal cancer patients.
Gastroenterology 1997;113(3):767-72.
1997: Stefano Cascinu; Sandro Barni; Roberto Labianca; E Del Ferro; Marco Rocchi; M Ligi; MA Pessi; Marina Cazzaniga; G Zamparelli; A Ardizzoia; G Ugolini; G Ghiandoni; G Luporini; Giuseppe Catalano
Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1997;5(4):314-7.
1997: Stefano Cascinu; E Del Ferro; I Barbanti; M Ligi; A Fedeli; Giuseppe Catalano
Tumor markers in the diagnosis of malignant serous effusions.
American journal of clinical oncology 1997;20(3):247-50.
1997: Stefano Cascinu; Vincenzo Catalano; MARIO SCARTOZZI; Anna Maria Baldelli; Riccardo Cellerino
Liver metastases from colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(4):393-9.
1997: Roberto Labianca; Stefano Cascinu; Luciano Frontini; Sandro Barni; Giammaria Fiorentini; Giuseppe Comella; alberto zaniboni; O Gottardi; E Arnoldi; Cristina Oliani; Maria Duro; G Pavanato; Giancarlo Martignoni; A Raina; Elena Piazza; G Dallavalle; R Valsecchi; Gianfranco Pancera; G Luporini
High-versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a 'GISCAD' phase III study. Italian Group for the Study of Digestive Tract Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(2):169-74.
1996: Stefano Cascinu; E Del Ferro; C Grianti; M Ligi; Giuseppe Catalano
S-phase fraction and tumor aneuploidy in colorectal carcinoma of young patients.
Cancer 1996;78(9):1857-60.
1996: Stefano Cascinu; G Catalano; Riccardo Cellerino
Recombinant human erythropoietin in chemotherapy-associated anemia.
Cancer treatment reviews 1996;21(6):553-64.
1996: A Piga; Stefano Cascinu; L Latini; M Marcellini; M Bavosi; Luigi Acito; R Bascioni; Lucio Giustini; G Francini; A Pancotti; G Rossi; M Del Papa; Flavia Carle; Riccardo Cellerino
A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer.
British journal of cancer 1996;74(6):971-4.
1996: Stefano Cascinu; E Del Ferro; Giuseppe Catalano
Toxicity and therapeutic response to chemotherapy in patients aged 70 years or older with advanced cancer.
American journal of clinical oncology 1996;19(4):371-4.
1996: Stefano Cascinu; E Del Ferro; M Ligi; Giuseppe Catalano
A phase I trial of 5-fluorouracil, leucovorin and interferon-alpha 2b administered by 24 h infusion in metastatic colorectal carcinoma.
Anti-cancer drugs 1996;7(5):520-4.
1996: Stefano Cascinu; E Del Ferro; M Ligi; Graziano Francesco; A Castellani; Giuseppe Catalano
Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):538.
1996: Stefano Cascinu; V Casadei; E Del Ferro; Paolo Alessandroni; Giuseppe Catalano
Pamidronate in patients with painful bone metastases, who failed initial treatment with hormones and/or chemotherapy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1996;4(1):31-3.
1996: Stefano Cascinu; E Del Ferro; Giuseppe Catalano
Different doses of granulocyte colony stimulating factor to support a weekly chemotherapeutic regimen in advanced gastric cancer: a randomized study.
Anti-cancer drugs 1996;7(1):43-7.
1996: Stefano Cascinu; Paolo Alessandroni; D Rossi; E Del Ferro; A Fedeli; V Casadei; Giuseppe Catalano
Multimodal biochemical modulation of 5-fluorouracil by leucovorin, methotrexate, and interferon alpha in patients with advanced colorectal cancer.
Cancer chemotherapy and pharmacology 1996;38(4):385-6.
1995: Stefano Cascinu; L Latini; A Fedeli; Paolo Giordani; S Antognoli; Giuseppe Catalano; Riccardo Cellerino
The clinical impact of FEM regimen (5-fluorouracil, 4-epidoxorubicin and mitomycin-C) in advanced gastric cancer patients.
Anticancer research 1995;15(6B):2781-3.
1995: Stefano Cascinu; Giuseppe Catalano
Have enteric infections a role in 5-fluorouracil-associated diarrhea?
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1995;3(5):322-3.
1995: Stefano Cascinu; E Del Ferro; A Fedeli; M Ligi; Paolo Alessandroni; Giuseppe Catalano
Recombinant human erythropoietin treatment in elderly cancer patients with cisplatin-associated anemia.
Oncology 1995;52(5):422-6.
1995: Stefano Cascinu; Giuseppe Catalano
Escalating dose of tegafur combined with oral etoposide in metastatic gastric carcinoma.
Anti-cancer drugs 1995;6(4):608-11.
1995: Stefano Cascinu
Management of diarrhea induced by tumors or cancer therapy.
Current opinion in oncology 1995;7(4):325-9.
1995: Stefano Cascinu; E Del Ferro; Giuseppe Catalano
A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy.
British journal of cancer 1995;71(1):97-101.
1995: Stefano Cascinu; L Cordella; E Del Ferro; M Fronzoni; Giuseppe Catalano
Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):26-32.
1994: Stefano Cascinu; A Veraldi; G P Foglietti; R Ghiselli; V Saba; F Lungarotti; L Babini; Giuseppe Catalano
A pilot clinical trial of surgical adjuvant treatment with high-dose 6S-leucovorin/5-fluorouracil and radiation therapy for high-risk rectal carcinoma.
Tumori 1994;80(5):335-8.
1994: Stefano Cascinu; A Fedeli; S L Fedeli; Giuseppe Catalano
Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis.
European journal of cancer. Part B, Oral oncology 1994;30B(4):234-6.
1994: Stefano Cascinu; A Fedeli; E Del Ferro; S Luzi Fedeli; Giuseppe Catalano
Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(5):1058-62.
1994: Stefano Cascinu; A Fedeli; S Luzi Fedeli; Giuseppe Catalano
Cisplatin, 5-fluorouracil and interferon alpha 2b for recurrent or metastatic head and neck cancer.
British journal of cancer 1994;69(2):392-3.
1994: Stefano Cascinu; A Fedeli; S L Fedeli; Giuseppe Catalano
Control of chemotherapy-induced diarrhea with octreotide. A randomized trial with placebo in patients receiving cisplatin.
Oncology 1994;51(1):70-3.
1994: Stefano Cascinu; A Fedeli; Giuseppe Catalano
Etoposide, leucovorin, 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: a pilot study.
Cancer chemotherapy and pharmacology 1994;34(1):72-4.
1993: Stefano Cascinu; E Del Ferro; A Fedeli; C Grianti; G Foglietti; Q Olivieri; M Acetoso; M Bartolucci; V Saba; F Lungarotti
Cytokinetic effects of interferon in colorectal cancer tumors: implications in the design of the interferon/5-fluorouracil combinations.
Cancer research 1993;53(22):5429-32.
1993: Stefano Cascinu; G Valentini; Giuseppe Catalano
A pilot clinical trial of postoperative adjuvant intraperitoneal cisplatin, 5-fluorouracil, 6S-leucovorin and interferon alpha 2b in patients with resected gastric cancer.
Tumori 1993;79(5):331-5.
1993: Stefano Cascinu; A Fedeli; S L Fedeli; Giuseppe Catalano
5-Fluorouracil, leucovorin and interferon alpha 2b in advanced pancreatic cancer: a pilot study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(1):83-4.
1993: Stefano Cascinu; A Fedeli; S L Fedeli; Giuseppe Catalano
Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study.
British journal of cancer 1993;67(1):156-8.
1993: Stefano Cascinu; A Fedeli; S L Fedeli; Giuseppe Catalano
Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(1):148-51.
1993: Stefano Cascinu; A Fedeli; Giuseppe Catalano
Breast cancer developing after therapy for Hodgkin's disease.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1993;5(1):61-2.
1993: Roberto Labianca; Gianfranco Pancera; Sandro Barni; Stefano Cascinu; Giuseppe Comella; P Foa; Giancarlo Martignoni; alberto zaniboni; G Giaccon; G Luporini
Biochemical modulation of fluoropyrimidines: the "GISCAD" studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer).
Advances in experimental medicine and biology 1993;339():233-7.
1992: Stefano Cascinu; A Fedeli; S Luzi Fedeli; Giuseppe Catalano
Treatment of elderly advanced gastric cancer patients with 5-fluorouracil and leucovorin combination.
Journal of chemotherapy (Florence, Italy) 1992;4(3):185-8.
1992: Stefano Cascinu; A Fedeli; S L Fedeli; Giuseppe Catalano
Double biochemical modulation of 5-fluorouracil by leucovorin and cyclic low dose interferon alpha 2b in advanced colorectal cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(6):489-91.
1992: Stefano Cascinu; A Fedeli; S Luzi Fedeli; Giuseppe Catalano
Salvage chemotherapy in colorectal cancer patients with good performance status and young age after failure of 5-fluorouracil/leucovorin combination.
Journal of chemotherapy (Florence, Italy) 1992;4(1):46-9.
1992: Stefano Cascinu; A Fedeli; S L Fedeli; Giuseppe Catalano
Control of chemotherapy-induced diarrhoea with octreotide in patients receiving 5-fluorouracil.
European journal of cancer (Oxford, England : 1990) 1992;28(2-3):482-3.
1991: Stefano Cascinu; P P Isidori; A Fedeli; S L Fedeli; M Raspugli; A Rossi; M Ugolini; Giuseppe Catalano
Experience with intrapleural natural beta interferon in the treatment of malignant pleural effusions.
Tumori 1991;77(3):237-8.
1991: Stefano Cascinu; A Fedeli; S Luzi Fedeli; Giuseppe Catalano
5-Fluorouracil dose intensity increase in 5-fluorouracil and leucovorin combination: results of a phase II study.
Journal of chemotherapy (Florence, Italy) 1991;3(1):51-4.
1989: Stefano Cascinu; S Luzi Fedeli; A Fedeli; Giuseppe Catalano
Gastric metastases from breast cancer: a case report.
Tumori 1989;75(2):150-1.